BioIVT

Westbury, United States Founded: 2015 • Age: 11 yrs Acquired By Linden Capital Partners
Provider of in vitro diagnostic products and assay services
Request Access

About BioIVT

BioIVT is a company based in Westbury (United States) founded in 2015 was acquired by Linden Capital Partners in October 2021.. BioIVT has completed 19 acquisitions, including Ascendance Biotechnology, Asterand Bioscience and Biological Specialty. BioIVT operates in a competitive market with competitors including Bio Rad, Abcam, Siemens Healthineers, Merck and Quanterix, among others.

  • Headquarter Westbury, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of BioIVT
Headcount 50-200
Employee Profiles 127
Employee Profiles
People
Nadine Zainudeen
Business Development Manager
People
Dave Yoder
Senior Business Analyst
People
Kieran K.
European Operations Manager (Donor Centres)
People
Amelia Sugianto
Director Of Strategic Initiatives

Unlock access to complete

Funding Insights of BioIVT

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $22,565
  • First Round

    (06 Jan 2010)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2021 Amount Grant - BioIVT Valuation

investors

Jan, 2010 Amount Grant - BioIVT Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BioIVT

BioIVT has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Linden Capital Partners and Lineage Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Lineage Capital is engaged in private equity partnerships.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Private equity investments are focused on the healthcare sector.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BioIVT

BioIVT has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include Ascendance Biotechnology, Asterand Bioscience and Biological Specialty. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic, and diagnostic product development.
2015
Biotech models for drug safety and interaction predictions are provided.
2012
Novel drug assays from explant-derived human primary cells are developed.
2011
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - BioIVT

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bioivt Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BioIVT

BioIVT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Abcam, Siemens Healthineers, Merck and Quanterix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Portfolio of products and services for life science research and clinical diagnostic markets
domain founded_year HQ Location
Biological reagents and antibodies are developed for life science research.
domain founded_year HQ Location
AI-based medical diagnostics are developed for healthcare applications.
domain founded_year HQ Location
Merck is engaged in science and technology solutions globally.
domain founded_year HQ Location
Assay kits for ultra-sensitive biomarker detection are developed.
domain founded_year HQ Location
Developer of cell culture media and ancillary reagents for life science research
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bioivt

Frequently Asked Questions about BioIVT

When was BioIVT founded?

BioIVT was founded in 2015.

Where is BioIVT located?

BioIVT is headquartered in Westbury, United States. It is registered at Westbury, New York, United States.

What does BioIVT do?

Provider of in vitro diagnostic products and assay services. The company specializes in control and disease state matrices manufactured from human and animal blood, plasma, serum, tissues, and other fluids which are used in drug discovery, compound development, clinical and research diagnostics. They also provide hepatocyte and microsome products used in the preclinical industry. It provides in-vitro research services such as transporters assay, cell biology, gene expression, and drug-drug interaction assay.

Who are the top competitors of BioIVT?

BioIVT's top competitors include Abcam, Biocare Medical and Sino Biological.

How many acquisitions has BioIVT made?

BioIVT has made 19 acquisitions, including Ascendance Biotechnology, Asterand Bioscience, and Biological Specialty.

Who are BioIVT's investors?

BioIVT has 4 investors. Key investors include European Union, Linden Capital Partners, Lineage Capital, and National Science Foundation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available